Study Reinforces Role Of AED Vimpat (Lacosamide) (C-V) As Add-On Treatment For POS

Links shared publicly online about this topic.

  • 1,320
    total visits

Study Reinforces Role Of AED Vimpat (Lacosamide) (C-V) As Add-On Treatment For POS

medicalnewstoday.com

UCB has announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according

View full resource at medicalnewstoday.com

Tags: Seizure, Epilepsy, Drug, UCB

  • Share

Most Recently Shared on March 13, 2010 at 5:05 am By:

mnt_clinical MNT Clinical Trials

Study Reinforces Role Of AED Vimpat (Lacosamide) (C-V) As Add-On Treatment For POS http://mnt.to/3yQt #clinicaltrials

2 years ago...

Also Shared By:

MNT Epilepsy News MNT Epilepsy News

MNT Drug Approvals MNT Drug Approvals

Newly-Published Study Reinforces Role Of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) As An Add-on Treatment That Significantly Reduces Epilepsy

medicalnewstoday.com — “UCB announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 12, 2010 at 3:11 pm By:

mnt_epilepsy MNT Epilepsy News Health News

Newly-Published Study Reinforces Role Of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) As An Add-on Treatment That S... http://mnt.to/3yQ3

2 years ago...

Advertisement